The short answer
An important reduction in atorvastatin effectiveness from oat bran has not been established in people. An animal experiment raises a possible concern, but it does not provide a proven human timing rule. Discuss concentrated fiber supplements if your cholesterol response changes.
What this answer covers
Oral atorvastatin and Avena sativa oat bran. Ordinary oat foods, concentrated bran and other fibers are not treated as identical exposures.
- Supplement or preparation
- oat bran
- Medication ingredient
- atorvastatin
What has been studied?
A sixteen-week experiment in mice found that a diet rich in oat bran weakened the response to low-dose atorvastatin. The same significant difference was not seen at the higher drug dose. Investigators proposed reduced intestinal absorption, but the study did not directly measure drug uptake in people.
Can findings from another statin answer the question?
An older fiber report names lovastatin, a different medicine. It does not establish an effect of oat bran on atorvastatin. The direct atorvastatin experiment was in mice, and a corresponding human effect remains uncertain.
Do I need a fixed gap?
No tested human interval was identified for this exact combination. Atorvastatin instructions permit use with or without food; that does not specifically test a large bran supplement. A pharmacist can consider your dose, supplement quantity and routine without assuming a fixed two-hour gap has been tested.
How can the response be checked?
Keep the prescribed statin schedule and discuss substantial changes in fiber supplementation with your clinician. A follow-up LDL result can help assess overall treatment response. A change in cholesterol alone would not identify fiber as the cause; adherence and other changes also need assessment.
Evidence and practical considerations
Absorption & effectiveness
An important reduction in atorvastatin effectiveness from oat bran has not been established in people. An animal experiment raises a possible concern, but it does not provide a proven human timing rule. Discuss concentrated fiber supplements if your cholesterol response changes.
- Exact scope
- Oral atorvastatin and Avena sativa oat bran. Ordinary oat foods, concentrated bran and other fibers are not treated as identical exposures. with Exact RxNorm 83367, IN, atorvastatin. LIPITOR contains atorvastatin calcium trihydrate, with strength expressed as atorvastatin active moiety in the label. This is the explicit salt-to-IN bridge.
- Medication form and route
- oral
What remains uncertain
- No controlled human exact-pair effect or validated spacing interval located. Animal findings and an inaccessible lovastatin report do not prove an atorvastatin interaction.
Factors that may matter: Exact preparation, dose, other medicines and baseline clinical condition matter..
Read the supporting source summaries
Source 1: regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral atorvastatin.
Provides grapefruit and lipid-modifying niacin precautions, symptom monitoring and once-daily administration with or without food.
How this applies: Restricted to the exact identities and conditions described in this article.
Absence of an ingredient from the label is not a negative interaction study. No pectin, oat bran or Panax-specific human effect size is supplied.
Source 2: original nonclinical study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Ninety female LDL-receptor-deficient mice, fifteen per group.
Oat bran reduced the low-dose atorvastatin lipid response; the higher-dose comparison did not show the same significant difference.
How this applies: Restricted to the exact identities and conditions described in this article.
Animal diet experiment. Decreased drug absorption was hypothesized rather than directly measured, and no human spacing interval was tested.
Source 3: original publication metadata, clinical body unavailable
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Not ascertainable from the inspected original record.
This original record establishes the identity of the cited report, but its clinical results could not be inspected.
How this applies: Restricted to the exact identities and conditions described in this article.
No abstract and failed publisher retrieval. Not used to assert case counts, changes in LDL, an atorvastatin effect or a spacing recommendation. Access enum abstract_only denotes limited record access here.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original-source assessment and consumer article prepared; exact claim dispositions, neutral findings and preparation limits recorded. | |
| Clinical sign-off is pending and no publication approval is asserted. | |
| Clarified evidence limits and source details after an independent editorial audit. Clinical review is still pending. | |
| Research summary published |
Article revision: b0af87592a7e5d3c
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.